Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-25-000059
Filing Date
2025-04-03
Accepted
2025-04-03 16:55:01
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1743713694.html 4  
1 FORM 4 wk-form4_1743713694.xml 4 5977
  Complete submission text file 0001764013-25-000059.txt   7541
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DERMAVANT SCIENCES, INC. 2398 E. CAMELBACK ROAD, SUITE 1060 PHOENIX AZ 85016
Business Address
Van Tuyl Christopher (Reporting) CIK: 0001779707 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 25810442